Expression of Platelet-Activating Factor Receptor: A Novel Prognosticator in Patients with Hepatocellular Carcinoma following Hepatectomy

Publisher： Karger

E-ISSN： 1423-0232|72|5-6|381-387

ISSN： 0030-2414

Source： Oncology, Vol.72, Iss.5-6, 2008-01, pp. : 381-387

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Expression of a splice variant of the platelet-activating factor receptor transcript 2 in various human cancer cell lines

By Youlyouz Ibtissam   Magnoux Emmanuelle   Guglielmi Laurence   Denizot Yves  

Mediators of Inflammation, Vol. 11, Iss. 5, 2002-10 ,pp. : 329-331

Informa Healthcare

Access to resources Recommend Favorite

Changes in serum alpha fetoprotein in patients with recurrent hepatocellular carcinoma following hepatectomy

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 9, 2015-09 ,pp. : 1405-1411

John Wiley & Sons Inc

Access to resources Recommend Favorite

Decreased levels of serum platelet-activating factor acetylhydrolase in patients with rheumatic diseases

By Vergne P.   Praloran V.   Treves R.   Denizot Y.  

Mediators of Inflammation, Vol. 6, Iss. 3, 1997-06 ,pp. : 241-242

Informa Healthcare

Access to resources Recommend Favorite

Survival benefit with IMRT following narrow‐margin hepatectomy in patients with hepatocellular carcinoma close to major vessels

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 12, 2015-12 ,pp. : 2603-2610

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Significance of Fibroblast Growth Factor Receptor 2 Expression in Differentiation of Hepatocellular Carcinoma

By  

Oncology, Vol. 78, Iss. 5-6, 2010-08 ,pp. : 361-368

Karger

Access to resources Recommend Favorite